Have your own idea? Try our Stock Screener
Israeli (TA) Healthcare Sector Analysis
UpdatedAug 28, 2026
DataAggregated Company Financials
Companies39
- 7D1.5%
- 3M-12.3%
- 1Y-4.5%
- YTD-5.4%
The Healthcare industry is up 1.9% in the last week, with Rafa Laboratories up 9.7%. Meanwhile, BrainsWay actually underperformed within the industry, shrinking 5.5% in the last week. In the past year, the industry is down 5.5%. Earnings are forecast to grow by 28% annually.
Sector Valuation and Performance
Has the Israeli Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 28 Aug 2026 | ₪14.3b | ₪8.5b | ₪508.0m | 14.5x | 28.1x | 1.7x |
| Sun, 26 Jul 2026 | ₪15.1b | ₪8.4b | ₪486.4m | 18.7x | 31x | 1.8x |
| Tue, 23 Jun 2026 | ₪13.5b | ₪8.0b | ₪413.3m | 17.3x | 32.6x | 1.7x |
| Thu, 21 May 2026 | ₪14.0b | ₪7.9b | ₪445.4m | 17.1x | 31.4x | 1.8x |
| Sat, 18 Apr 2026 | ₪14.8b | ₪7.8b | ₪397.4m | 19.1x | 37.2x | 1.9x |
| Mon, 16 Mar 2026 | ₪13.9b | ₪8.0b | ₪295.5m | 17.5x | 47.2x | 1.7x |
| Wed, 11 Feb 2026 | ₪14.2b | ₪7.9b | ₪366.0m | 21.5x | 38.8x | 1.8x |
| Fri, 09 Jan 2026 | ₪13.9b | ₪8.0b | ₪366.2m | 21.5x | 38.1x | 1.7x |
| Sun, 07 Dec 2025 | ₪12.9b | ₪5.8b | ₪221.9m | 20.1x | 57.9x | 2.2x |
| Tue, 04 Nov 2025 | ₪10.4b | ₪5.8b | ₪194.3m | 17x | 53.7x | 1.8x |
| Thu, 02 Oct 2025 | ₪10.1b | ₪5.9b | ₪197.3m | 16.6x | 51x | 1.7x |
| Sat, 30 Aug 2025 | ₪10.1b | ₪5.9b | ₪220.1m | 13.5x | 45.8x | 1.7x |
| Mon, 28 Jul 2025 | ₪10.0b | ₪5.9b | ₪110.9m | 17.1x | 90.6x | 1.7x |
| Wed, 25 Jun 2025 | ₪9.6b | ₪5.9b | ₪109.9m | 18.1x | 87.1x | 1.6x |
| Fri, 23 May 2025 | ₪9.5b | ₪5.9b | ₪152.3m | 13.7x | 62.1x | 1.6x |
| Sun, 20 Apr 2025 | ₪9.1b | ₪6.0b | ₪110.4m | 14.1x | 82.4x | 1.5x |
| Tue, 18 Mar 2025 | ₪9.6b | ₪5.9b | -₪122,330,778.50 | 14.5x | -78.4x | 1.6x |
| Thu, 13 Feb 2025 | ₪10.1b | ₪5.9b | -₪150,469,402.60 | 14.7x | -67.1x | 1.7x |
| Sat, 11 Jan 2025 | ₪9.8b | ₪5.9b | -₪156,751,462.80 | 15.4x | -62.6x | 1.7x |
| Mon, 09 Dec 2024 | ₪9.3b | ₪5.9b | -₪155,340,323.20 | 18.3x | -59.6x | 1.6x |
| Wed, 06 Nov 2024 | ₪8.9b | ₪5.8b | -₪271,081,891.90 | 14.6x | -32.8x | 1.5x |
| Fri, 04 Oct 2024 | ₪8.5b | ₪5.8b | -₪279,597,395.30 | 14.1x | -30.2x | 1.4x |
| Sun, 01 Sep 2024 | ₪8.5b | ₪5.8b | -₪250,255,149.70 | 17.4x | -33.9x | 1.5x |
| Tue, 30 Jul 2024 | ₪8.5b | ₪5.9b | -₪467,758,346.10 | 16.2x | -18.2x | 1.5x |
| Thu, 27 Jun 2024 | ₪7.9b | ₪5.9b | -₪465,227,733.20 | 14.9x | -16.9x | 1.3x |
| Sat, 25 May 2024 | ₪8.3b | ₪5.7b | -₪503,002,324.10 | 19.3x | -16.6x | 1.5x |
| Mon, 22 Apr 2024 | ₪8.3b | ₪5.8b | -₪520,364,025.00 | 20.6x | -16x | 1.4x |
| Wed, 20 Mar 2024 | ₪8.8b | ₪5.6b | -₪464,650,035.00 | 19.1x | -19x | 1.6x |
| Fri, 16 Feb 2024 | ₪8.8b | ₪5.6b | -₪485,165,729.20 | 18.5x | -18.1x | 1.6x |
| Sun, 14 Jan 2024 | ₪9.0b | ₪5.7b | -₪591,665,126.00 | 15.3x | -15.2x | 1.6x |
| Tue, 12 Dec 2023 | ₪8.3b | ₪5.7b | -₪580,109,368.00 | 15.3x | -14.2x | 1.4x |
| Thu, 09 Nov 2023 | ₪8.3b | ₪5.6b | -₪605,213,077.00 | 12.8x | -13.7x | 1.5x |
| Sat, 07 Oct 2023 | ₪8.8b | ₪5.6b | -₪607,220,451.00 | 13.6x | -14.5x | 1.6x |
| Mon, 04 Sep 2023 | ₪8.4b | ₪5.6b | -₪555,739,361.00 | 13.7x | -15.1x | 1.5x |
Price to Earnings Ratio
-15.1x
Current Industry PE
- Investors are optimistic on the Israeli Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 31.0x which is higher than its 3-year average PE of 18.1x.
- The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 15% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare sector?
| IL Market | 1.65% | |
| Healthcare | 1.54% | |
| Life Sciences | 18.84% | |
| Pharma | 9.92% | |
| Biotech | 2.56% | |
| Healthtech | 0% | 0 |
| Healthcare Services | -0.12% | |
| Medical Equipment | -0.36% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 10.5x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 36% over the next 5 years.
- This is better than its past earnings growth rate of 15% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RAFA Rafa Laboratories | ₪16.00 | 9.7% +₪139.1m | n/a | PE12.7x | |
| SOFW SofWave Medical | ₪37.20 | 6.3% +₪80.2m | 38.1% | PE51.2x | |
| INCR InterCure | ₪17.11 | 32.7% +₪46.1m | -36.2% | PS0.7x | |
| KMDA Kamada | ₪24.28 | 2.6% +₪35.8m | 4.8% | PE21.2x | |
| NVLG Novolog (Pharm-Up 1966) | ₪0.80 | 9.3% +₪34.7m | -45.2% | PS0.2x |